Indian Journal of Physical Medicine and Rehabilitation

Register      Login

VOLUME 26 , ISSUE 1 ( March, 2015 ) > List of Articles

RESEARCH ARTICLE

Clinical and Imaging Evaluation of Efficacy of Viscosupplementation in Degenerative Osteo-arthritis Knee – A Prospective Interventional Study

Rohini Gupta, SY Kothari, Jaydeep Nandi, Diganta Borah, BB Thukral

Citation Information : Gupta R, Kothari S, Nandi J, Borah D, Thukral B. Clinical and Imaging Evaluation of Efficacy of Viscosupplementation in Degenerative Osteo-arthritis Knee – A Prospective Interventional Study. Indian J Phy Med Rehab 2015; 26 (1):6-10.

DOI: 10.5005/ijopmr-26-1-6

Published Online: 01-03-2015

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract

In this study 30 patients with osteo-arthritis (OA) knee (total 55 knees) were given weekly injections of high molecular weight (HMW) hyaluronic acid (HA) for 3 weeks. The subjective parameter was Western Ontario and McMaster Universities Index of Osteoarthritis (WOMAC) score which improved from 97.67±21.4 at baseline to 61.03±24.8 at six months follow-up (p=0.0001). Also the mean range of motion (ROM) of the involved knees was 125.73± 10.8 degrees at baseline and it increased to 132.64±5.2 degrees after six months (p=0.0001) of injection treatment. The objective parameter of disease modification was MRI based semi-quantitive Whole-organ Magnetic Resonence Imaging Score (WORMS) score. The mean of total WORMS score in medial femorotibial joint (MFTJ) and patellofemoral joint (PFJ) improved from baseline (28.382±10.446; 22.64±5.969) to final follow up (27.46±10.32; 21.76± 6.182) which was quite significant (p=0.0321; p=0.0294) and implies a reduced rate of cartilage destruction after injection HA though there is no regrowth of cartilage as such.


PDF Share
  1. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-10.
  2. Burden of Major Musculoskeletal Conditions. Policy and Practice. Special Theme-Bone and Joint Decade 2000-2010. Bull of the World Health Organ 2003;81:646-656.
  3. A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria. Arthritis Res Ther 2007;9:126-34.
  4. Visco-supplementation for osteoarthritis: current status, unresolved issues and future directions. J Rheumatol 1998;25:2056-8.
  5. Lancet 2011;377:2115-26.
  6. Intra-articular injection of hyaluronan as treatment for knee osteoarthritis. What is the evidence? Arthritis Rheum 2000;43:1192-203.
  7. Visco-supplementation for the treatment of osteoarthritis of the knee. Cochrane Database of Systematic Reviews 2006;Issue 2:
  8. OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99.
  9. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthritis Cartilage 2011;19:606-10.
  10. Predictors of clinical response to intraarticular hylan injections -a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging. J Rheumatol 2008;35:4685-90.
  11. Effects of hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskeletal Disorde 2011;12:195.
  12. Preliminary evaluation of potential disease modification by hylan G-F 20 (Synvisc®) using dGEMRIC. J Mol Imag Dynamic 2012;2:104.
  13. Determination of cartilage volume using MRI in patients with knee osteoarthritis: efficacy study of 25 milligrams of sodium hyaluronate (2.5 Ml) versus placebo. Clin Exp Pharmacol 2012;112. doi:10.4172/2161-1459.1000112
  14. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 2004;12:177-90.
  15. Defining osteoarthritis for epidemiological purpose. In: Buckwalter Joseph A, Goldberg Victor M, editors. Osteoarthritis: Diagnosis and Medical/Surgical Management. 4th ed. London: Lippincot & Williams, 2007:35-9.
  16. Osteoarthritis and disk degeneration in an urban population. Ann of Rheum 1958;17:388-97.
  17. Pain assessment in osteoarthritis: Experience with the WOMAC osteoarthritis index. Semin Arthritis Rheum 1989;18:14-7.
  18. Intra articular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 1998;25:2203-12 [Published erratum appears in J Rheumatol 1999;26:1216].
  19. The effectiveness and safety of intra-articular injection of sodium hyaluronate (500-730 Kda) in the Ttreatment of patients with painful knee osteoarthritis. J Med Assoc Thai 2009;92:1287-94.
  20. Open label multi centre trial on safety and efficacy of intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee–a prospective study. JIACM 2005;6:232-5.
  21. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee–a long term study. Eur Rheum Inflamm 1995;15:57-62.
  22. Intra-articular sodium hyaluronate (Hyalgan) in gonarthritis. Clin Trials J 1987;24:341-350.
  23. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cart 1997;5:153-60.
  24. Visco-supplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996;23:1579-85.
  25. Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post operative pain. Mol Pain 2009;5:32.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.